Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus

Gomes, Marilia Brito; Cobas, Roberta Arnold; Nunes, Edson; Faria Neto, Hugo Caire de Castro; Matta, Maria Fátima Bevilacqua da; Neves, Ricardo; Tibiriçá, Eduardo

Brasil | Article

Registro en:

GOMES, Marilia Brito; et al. Plasma PAF-acetylhydrolase activity, inflammatory markers and susceptibility of LDL to in vitro oxidation in patients with type 1 diabetes mellitus. Diabetes Research and Clinical Paractice, v.85, p.61-68, May 2009.

0168-8227

https://www.arca.fiocruz.br/handle/icict/30851

10.1016/j.diabres.2009.04.016

1872-8227

https://repositorioslatinoamericanos.uchile.cl/handle/2250/8852550

Autor

Gomes, Marilia Brito

Cobas, Roberta Arnold

Nunes, Edson

Faria Neto, Hugo Caire de Castro

Matta, Maria Fátima Bevilacqua da

Neves, Ricardo

Tibiriçá, Eduardo

Institución

Instituto de Comunicação e Informação Científica e Tecnológica em Saúde (Brasil)

Resumen

We evaluated if type 1 diabetic patients have altered levels of low-grade inflammatory markers including platelet-activating factor acetylhydrolase (PAF-AH) activity, high-sensitivity C-reactive protein (hs-CRP), white blood cells count (WBC), erythrocyte sedimentation rate (ESR) and LDL-cholesterol oxidation coefficient (OxC), and whether their levels are related to clinical complications and the metabolic profile.

2030-01-01

Materias

Diabetes tipo 1

Marcadores Inflamatórios

Complicações crônicas

Chronic complications

Mostrar el registro completo del ítem